|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61K 31/4985 | |||
| C07C 211/42 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61P 25/00 |
| (11) | Number of the document | 1904066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06786496.7 |
| Date of filing the European patent application | 2006-07-06 | |
| (97) | Date of publication of the European application | 2008-04-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/026361 |
| Date | 2006-07-06 |
| (87) | Number | WO 2007/006003 |
| Date | 2007-01-11 |
| (30) | Number | Date | Country code |
| 697013 P | 2005-07-06 | US |
| (72) |
CARON, Judy, US
WESSEL, Thomas, US
LALJI, Karim, CA
VARNEY, Mark, US
BAKALE, Roger P., US
SINGH, Surendra P., US
WILKINSON, H. Scott, US
SU, Xiping, US
HAN, Zhengxu, US
KOENIG, Stephan G., US
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS |
| COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS |